C2A Security

C2A Security's principal product is EVSec, a product-security operating layer for organizations that build and maintain software-defined or cyber-physical products. The platform models a product and its components, then links threat analysis and risk assessment (TARA), SBOM and other bill-of-materials data, vulnerabilities, security testing, compliance controls, and remediation workflows. C2A's current product materials describe modules for AI-assisted threat modeling, source-code and binary analysis, BOM and vulnerability management, penetration and fuzz testing, product-contextual threat intelligence, SOC enrichment, and automated workflows. The important technical proposition is not simply finding more vulnerabilities; it is contextualizing a vulnerability against a particular product architecture, component, software version, business impact, and regulatory obligation so engineering teams can make defensible decisions.

The initial market was automotive cybersecurity, where connected vehicles, OTA updates, complex tiered suppliers, and UN Regulation No. 155 and ISO/SAE 21434 create a recurring need for traceability and a living cybersecurity management system. C2A now presents EVSec across automotive and mobility, medical devices, industrial and IoT systems, and robotics. The customer problem is similar across those segments: product security evidence becomes stale when a component, supplier, CVE, architecture, or regulation changes, while responsibility is distributed across product engineering, security, quality, compliance, and external suppliers. Integrations advertised for CI/CD, PLM, ticketing, security operations, BOM formats, and vulnerability intelligence suggest an enterprise workflow product that must fit into existing engineering systems rather than operate as an isolated scanner.

The competitive position is therefore vertical and workflow-oriented. C2A competes with automotive-security platforms such as Cybellum, Upstream Security, and Argus-adjacent offerings; with medical-device and product-security specialists such as MedCrypt and Vigilant Ops-derived capabilities; and with broader application-security, ASPM, SBOM, and OT-security tools such as ArmorCode, Snyk, and Nozomi Networks. C2A's claimed differentiation is the connected model between TARA, BOM intelligence, vulnerability impact, compliance reporting, and supplier collaboration. That can be valuable when an OEM or device manufacturer needs one risk picture across product lifecycle stages, but it also creates a high bar for data quality, integrations, explainability, and proof that automation is reliable enough for regulated decisions.

There are credible commercialization signals, although they should not be confused with disclosed financial scale. LinkedIn identifies the company as privately held, founded in 2016, headquartered in Jerusalem, and in the 11-50 employee range. Public company announcements describe a multi-year enterprise agreement with Elekta for medical-device product security and compliance, and a 2025 acquisition of Pittsburgh-based Vigilant Ops to add SBOM automation and healthcare expertise. Reuters also reported a cybersecurity-platform agreement with Daimler Truck in 2024. These are useful evidence of enterprise engagement and expansion beyond automotive, but public sources do not establish ARR, retention, margins, total active customers, or the economics and integration status of the acquisition. The company’s own performance claims, such as faster TARA or lower development cost, should be tested against customer references and implementation data.

For national-security and dual-use analysis, C2A has substantive but indirect relevance. The platform’s core capabilities—software assurance, component and supplier visibility, vulnerability impact analysis, continuous compliance evidence, and security operations context—are applicable to defense contractors, telecom operators, critical infrastructure, and mission-critical embedded systems. The 2025 Vigilant Ops announcement explicitly discusses defense and telecom expansion, but the public record does not establish a dedicated defense product, government contract, or operational deployment in a defense program. The strongest thesis is therefore that C2A can become assurance infrastructure for complex regulated supply chains, including defense-adjacent manufacturing, rather than that it is a weapons or defense-native company. Its strategic value depends on demonstrating that its product model scales across heterogeneous architectures and that its AI-assisted recommendations remain auditable, secure, and useful under real operational pressure.